Cook starts drug-eluting stent trial in US:
This article was originally published in Clinica
Cook (Bloomington, Indiana) has begun the first clinical trial of its drug-eluting coronary stent for preventing restenoses in the US. The Logic PTX stent, which is coated with the anti-cancer drug, paclitaxel, will be tested in a study of around 800 patients. Enrolment is expected to be concluded in early 2002. The study also represents the first US trial of a paclitaxel-coated stent, says Cook, which has developed a proprietary polymer-free method of coating the stent with the drug.